APA

Kilic A., Ustunova S., Usta C., Bulut H., Meral I., Demirci Tansel C. & Gurel Gurevin E. (20200330). Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia-reperfusion injury and oxidative damage in isolated rat heart. : Canadian journal of physiology and pharmacology.

Chicago

Kilic Aysu, Ustunova Savas, Usta Cansu, Bulut Huri, Meral Ismail, Demirci Tansel Cihan and Gurel Gurevin Ebru. 20200330. Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia-reperfusion injury and oxidative damage in isolated rat heart. : Canadian journal of physiology and pharmacology.

Harvard

Kilic A., Ustunova S., Usta C., Bulut H., Meral I., Demirci Tansel C. and Gurel Gurevin E. (20200330). Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia-reperfusion injury and oxidative damage in isolated rat heart. : Canadian journal of physiology and pharmacology.

MLA

Kilic Aysu, Ustunova Savas, Usta Cansu, Bulut Huri, Meral Ismail, Demirci Tansel Cihan and Gurel Gurevin Ebru. Angiotensin II type 2 receptor blocker PD123319 has more beneficial effects than losartan on ischemia-reperfusion injury and oxidative damage in isolated rat heart. : Canadian journal of physiology and pharmacology. 20200330.